向DHX9触发瘤内在干扰素反应和复制压力在小细胞肺癌中
Takahiko Murayama1,2,3, Jun Nakayama4,5, Xinpei Jiang1,2,3,6
1Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Cancer discovery
|January 8, 2024
概括
在小细胞肺癌 (SCLC) 中准DHX9通过增加病毒模仿来激活先天免疫力. 缺少DHX9可降低瘤生长,并增强冷瘤的免疫疗法反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 通过病毒模拟激活先天免疫力,将"冷"瘤转化为"热".
- 细胞质核酸感应通路是这种免疫激活的关键.
研究的目的:
- 确定抑制小细胞肺癌 (SCLC) 病毒模拟的因素.
- 调查DHX9作为增强抗瘤免疫力的潜在目标.
主要方法:
- 基于CRISPR的RNA螺旋酶的屏幕. 在CRISPR的基础上,RNA螺旋酶的屏幕.
- 在SCLC模型中DHX9的耗尽.
- 对细胞质dRNA,R环,DNA损伤和复制压力的分析.
- 在体内瘤生长和免疫原微环境评估.
主要成果:
- 在SCLC中,DHX9被确定为双链RNA (dsRNA) 和R环的抑制剂.
- DHX9的枯竭诱导了细胞质dSRNA,R环,DNA损伤和复制压力.
- 删除DHX9减少了瘤生长,增加了瘤免疫性.
- 抑制DHX9增强了对免疫检查点封锁的反应能力.
结论:
- DHX9是瘤内在天生的免疫和复制压力的关键抑制剂.
- DHX9是SCLC和其他"冷"瘤的有希望的治疗标.
- 向DHX9可以增强抗瘤免疫力和免疫疗法的疗效.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
768
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
相关概念视频
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
